Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-17-004033
Filing Date
2017-04-17
Accepted
2017-04-17 17:12:48
Documents
68
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1134336
2 ex31-1.htm EX-31.1 10562
3 ex31-2.htm EX-31.2 10567
4 ex32-1.htm EX-32.1 5871
5 ex32-2.htm EX-32.2 5483
6 image_004.jpg GRAPHIC 16609
7 image_005.jpg GRAPHIC 33661
  Complete submission text file 0001493152-17-004033.txt   4018753

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE owcp-20161231.xml EX-101.INS 583274
9 XBRL SCHEMA FILE owcp-20161231.xsd EX-101.SCH 44133
10 XBRL CALCULATION FILE owcp-20161231_cal.xml EX-101.CAL 44788
11 XBRL DEFINITION FILE owcp-20161231_def.xml EX-101.DEF 122949
12 XBRL LABEL FILE owcp-20161231_lab.xml EX-101.LAB 284265
13 XBRL PRESENTATION FILE owcp-20161231_pre.xml EX-101.PRE 211808
Mailing Address 30 SHAHAM STREET P.O. BOX 8324 PETACH TIQWA L3 4918103
Business Address 30 SHAHAM STREET P.O. BOX 8324 PETACH TIQWA L3 4918103 972-3-919-1921
OWC Pharmaceutical Research Corp. (Filer) CIK: 0001431934 (see all company filings)

EIN.: 980573566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-54856 | Film No.: 17765272
SIC: 3841 Surgical & Medical Instruments & Apparatus